+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lymphoma Drugs Market Research Reports

Global Hodgkin Lymphoma Market and Competitive Landscape - 2020 - Product Thumbnail Image

Global Hodgkin Lymphoma Market and Competitive Landscape - 2020

  • Report
  • April 2020
From
CNS Lymphoma Market - Forecast (2020 - 2025) - Product Thumbnail Image

CNS Lymphoma Market - Forecast (2020 - 2025)

  • Report
  • March 2020
  • 104 pages
From
B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
B-Cell Lymphomas - Pipeline Insight, 2020 - Product Thumbnail Image

B-Cell Lymphomas - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
Hodgkin Lymphoma Treatment Market - Growth, Trends, and Forecast (2020 - 2025) - Product Thumbnail Image

Hodgkin Lymphoma Treatment Market - Growth, Trends, and Forecast (2020 - 2025)

  • Report
  • February 2020
  • 120 pages
From
Indolent Lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

Indolent Lymphoma - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
Small lymphocytic lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

Small lymphocytic lymphoma - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
MALT Lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

MALT Lymphoma - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
Mantle Cell Lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

Mantle Cell Lymphoma - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
B-cell Non-Hodgkin's Lymphoma - Market Insights, Epidemiology, and Market Forecast - 2028 - Product Thumbnail Image

B-cell Non-Hodgkin's Lymphoma - Market Insights, Epidemiology, and Market Forecast - 2028

  • Drug Pipelines
  • January 2020
  • 287 pages
From
The 2021-2026 World Outlook for Lymphoma Therapeutics - Product Thumbnail Image

The 2021-2026 World Outlook for Lymphoma Therapeutics

  • Report
  • December 2019
  • 299 pages
Lymphoma Treatment Market By Type (Non-Hodgkin Lymphoma and Hodgkin Lymphoma) and Drug (Opdivo, Adcetris, Rituxan, Keytruda, Revlimid, Imbruvica, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025 - Product Thumbnail Image

Lymphoma Treatment Market By Type (Non-Hodgkin Lymphoma and Hodgkin Lymphoma) and Drug (Opdivo, Adcetris, Rituxan, Keytruda, Revlimid, Imbruvica, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

  • Report
  • October 2019
  • 110 pages
From
Global Mantle Cell Lymphoma Therapeutics Market 2019-2023 - Product Thumbnail Image

Global Mantle Cell Lymphoma Therapeutics Market 2019-2023

  • Report
  • July 2019
  • 131 pages
From
Non-Hodgkin Lymphoma Treatment Market.: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025 - Product Thumbnail Image

Non-Hodgkin Lymphoma Treatment Market.: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • Report
  • June 2019
  • 100 pages
From
2019 Burkitt Lymphoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Burkitt Lymphoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 219 pages
From
2019 Cutaneous T-Cell Lymphoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Cutaneous T-Cell Lymphoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 173 pages
From
2019 Cutaneous B-Cell Lymphoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Cutaneous B-Cell Lymphoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 75 pages
From
2019 AIDS Related Primary CNS Lymphoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 AIDS Related Primary CNS Lymphoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 37 pages
From
2019 AIDS Related Lymphoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 AIDS Related Lymphoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 43 pages
From
Loading Indicator

Lymphoma encompasses a variety of blood cancers of the lymphatic system. Non-Hodgkin’s Lymphoma (NHL) for example, is diagnosed in over 100,000 every year in the US and EU combined. An array of expert reports in our Lymphoma Section enable you to investigate drug development strategies and market trends for NHL, Hodgkin’s Lymphoma, Skin Lymphoma, T-Cell Lymphoma, Indolent Lymphoma and other variants. Investigate key issues such as licensing, R&D, industry alliances, generic drugs (rituximab, bortezomib, doxorubicin, bleomycin, vinblastine, etc.) and the activities of major pharmaceutical players such as Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-La Roche, and Sanofi-Aventis. Show Less Read more

adroll